BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27887203)

  • 21. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging features of hepatic angiomyolipomas on real-time contrast-enhanced ultrasound.
    Wang Z; Xu HX; Xie XY; Xie XH; Kuang M; Xu ZF; Liu GJ; Chen LD; Lin MX; Lu MD
    Br J Radiol; 2010 May; 83(989):411-8. PubMed ID: 19723766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-Enhanced Ultrasound of Congenital and Infantile Hemangiomas: Preliminary Results From a Case Series.
    El-Ali AM; McCormick A; Thakrar D; Yilmaz S; Malek MM; Squires JH
    AJR Am J Roentgenol; 2020 Mar; 214(3):658-664. PubMed ID: 31967502
    [No Abstract]   [Full Text] [Related]  

  • 24. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
    Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-mode and contrast enhanced ultrasound guided biopsy of portal vein thrombosis. Value in the diagnosis of occult hepatocellular carcinoma in liver cirrhosis.
    Sparchez Z; Radu P; Zaharia T; Kacso G; Diaconu B; Grigorescu I; Badea R
    Med Ultrason; 2010 Dec; 12(4):286-94. PubMed ID: 21210013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biliary cystadenoma and cystadenocarcinoma: two rare cystic liver lesions.
    Koroglu M; Akhan O; Akpinar E; Oto A; Gumus B
    JBR-BTR; 2006; 89(5):261-3. PubMed ID: 17147015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.
    Martie A; Sporea I; Popescu A; Sirli R; Dănilă M; Serban C; Ardelean M; Bota S; Sendroiu M; Chisevescu D
    Med Ultrason; 2011 Jun; 13(2):108-13. PubMed ID: 21655536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging Features of Fibrolamellar Hepatocellular Carcinoma with Contrast-Enhanced Ultrasound.
    Dong Y; Wang WP; Mao F; Zhang Q; Yang D; Tannapfel A; Meloni MF; Neye H; Clevert DA; Dietrich CF
    Ultraschall Med; 2021 Jun; 42(3):306-313. PubMed ID: 32102105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast enhanced ultrasound for the diagnosis of liver hemangiomas - results of a Romanian multicentre study.
    Sirli R; Sporea I; Săndulescu DL; Popescu A; Dănilă M; Săftoiu A; Spârchez Z; Badea R
    Med Ultrason; 2015 Dec; 17(4):444-50. PubMed ID: 26649337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced ultrasonography for evaluation of cystic renal mass: in comparison to contrast-enhanced CT and conventional ultrasound.
    Xue LY; Lu Q; Huang BJ; Ma JJ; Yan LX; Wen JX; Wang WP
    Abdom Imaging; 2014 Dec; 39(6):1274-83. PubMed ID: 24929667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice.
    Sporea I; Badea R; Popescu A; Spârchez Z; Sirli RL; Dănilă M; Săndulescu L; Bota S; Calescu DP; Nedelcu D; Brisc C; Ciobâca L; Gheorghe L; Socaciu M; Martie A; Ioaniţescu S; Tamas A; Streba CT; Iordache M; Simionov I; Jinga M; Anghel A; Cijevschi Prelipcean C; Mihai C; Stanciu SM; Stoicescu D; Dumitru E; Pietrareanu C; Bartos D; Manzat Saplacan R; Pârvulescu I; Vădan R; Smira G; Tuţă L; Săftoiu A
    Ultraschall Med; 2014 Jun; 35(3):259-66. PubMed ID: 24563420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biliary cystic neoplasm: biliary cystadenoma and biliary cystadenocarcinoma].
    Kim HG
    Korean J Gastroenterol; 2006 Jan; 47(1):5-14. PubMed ID: 16434863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
    Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
    AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biliary cystadenoma and cystadenocarcinoma of the liver: 10 cases of a single center experience.
    Lee JH; Lee KG; Park HK; Lee KS
    Hepatogastroenterology; 2009; 56(91-92):844-9. PubMed ID: 19621714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast enhancement ultrasound application in focal liver lesions characterization: a retrospective study about guidelines application (SOCEUS-CEUS survey).
    D'Onofrio M; Romanini L; Serra C; Magnolfi F; Bertolotto M; Quaia E; Puntel G; Colleoni A; Fiorini E; Cenci C; Santi E; Ciaravino V; Laffranchi F; Catalano O; Cantisani V; Calliada F; Derchi L
    J Ultrasound; 2016; 19(2):99-106. PubMed ID: 27298641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
    Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Habermann C; Wessling J
    Ultraschall Med; 2011 Dec; 32(6):582-92. PubMed ID: 22161555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound.
    Wang ZL; Tang J; Weskott HP; Li JL; Wang W; Luo YK; An LC; Xu JH
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1511-9. PubMed ID: 18713302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast-enhanced ultrasound features of hepatocellular carcinoma not detected during the screening procedure.
    Dong Y; Wang WP; Mao F; Dietrich C
    Z Gastroenterol; 2017 Aug; 55(8):748-753. PubMed ID: 28799151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.